Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2026-02-28 @ 3:48 AM
Study NCT ID:
NCT02919059
Status:
UNKNOWN
Last Update Posted:
2017-03-29
First Post:
2016-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
Sponsor:
IInstituto Gallego de Medicina Vascular
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ESR-14-10158
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None